Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030.

 Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic

 

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings

 

The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s).

§  Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics.

§  A detailed review of the current market landscape of microbiome diagnostic tests, brief profiles of popular diagnostic developers and indicative list of screening and profiling test kits.

§  A detailed assessment of the current market landscape of FMT therapies, a geographical clinical trial analysis and information on various stool banks.

§  A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework.

§  An analysis of the varied microbiome-focused initiatives of big pharma players.

§  An analysis of the start-ups / small-sized players engaged in the development of microbiome therapeutics and diagnostics.

§  An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.

§  An analysis of the investments made at various stages of development in start-ups / small-sized companies.

§  An indicative list of contract manufacturers, in-house manufacturers and CROs that currently claim to have the necessary capabilities.

§  An assessment of the emerging role of big data highlighting efforts focused on the development and implementation of various algorithms / tools to analyze data generated from in the microbiome research.

§  An informative case study on the various other applications of microbiome products, such as agriculture, animal health, plant health, food products

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

segments:

§  Type of Therapy (Tx)

§  Prescription Drug

§  Prebiotics

§  Probiotics

                   

§  Type of Molecule (Tx)

§  Small Molecules

§  Biologics

 

§  Target Indication (Tx+Dx)

§  Acne Vulgaris

§  Atopic Dermatitis

§  Clostridium difficile Infection

§  Colorectal Cancer

§  Crohn’s Disease

§  Diabetes

§  Irritable Bowel Syndrome

§  Lactose Intolerance

§  Lung Cancer

§  Nonalcoholic steatohepatitis (NASH)

§  Obesity

§  Ulcerative colitis

 

§  Therapeutic Area (Tx+Dx)

§  Autoimmune Disorders

§  Dental Disorders

§  Digestive and Gastrointestinal Disorders

§  Dermatological Disorders

§  Infectious Disease

§  Metabolic Disorders

§  Oncology

§  Others

 

§  Key Geographical Regions (Tx+Dx)

§  North America

§  Europe

§  Asia-Pacific and Rest of the World

 

Key companies covered in the report

§  4D Pharma

§  Armata Pharmaceuticals

§  Evelo Biosciences

§  Rebiotix (Acquired by Ferring Pharmaceuticals)

§  Seres Therapeutics

§  Vedanta Biosciences

 

For more information please click on the following link: 

https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com

 

Other Recent Offerings:

1.     Antibody Drug Conjugates Market (5th Edition), 2019-2030

2.     Gene Therapy Market (3rd Edition), 2019 - 2030

3.      Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030

4.      Synthetic Lethality-based Drugs and Targets Market, 2019-2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

Comments

Post a Comment

Popular posts from this blog

A relatively larger proportion of these firms are headquartered in the US, claims Roots Analysis

  Lately, drug manufacturers have started showing evident interest in modular facilities and using modularity in design approaches owing to the amplified value of smaller production facilities, which are more efficient and flexible. The increased demand for multi-product, multi-purpose, smaller batch size facilities has also prompted equipment manufacturers to revisit their product offerings.   To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html   The USD xx billion (by 2030) financial opportunity within the modular facilities market has been analyzed across the following segments: ·        Type of Modular Construct  §   Hybrid Skid §   Plug-and-Play §   Skid-Mounted §   Truckable §   Others §   Type of Construc...
Read more

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

    Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals   Roots Analysis is pleased to announce the publication of its recent study, titled “ Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 ” report to its list of offerings.   The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the r...
Read more

PRE-INSTALLED SINGLE-USE SENSORS FOR BIOPROCESSING-CASE STUDY

    During our research, we identified 31 pre-installed single-use sensors developed by various companies for bioprocessing. The current market landscape is predominantly characterized by the presence of large (38%) and small (37%) players. Notable examples of large players in this domain include ( in alphabetical order ) Cytiva Life Sciences (US), Hamilton (US) and Pall (US).   To Request Sample Pages -: https://www.rootsanalysis.com/reports/single-use-sensors-for-bioprocessing.html       Majority of the pre-installed single-use sensor systems are designed for both, research and biomanufacturing purposes. This is followed by those designed for only research purposes. Notable examples of products which are developed for both research and biomanufacturing applications, include ( arranged alphabetically ) ÄKTA ready XL sensor technology (Cytiva Life Sciences), Allegro™ MVP Single-Use System (Pall Corporation) and FUTURA pico (Aber Instruments)...
Read more